Skip to content
Screener

Editas Medicine EDIT Q1 2026 earnings

Reported May 5, 2026 · Before market open

Revenue$2.8MMiss by $3.5M
EPS-$0.26Beat by $0.04
Revenue estimate$6.4M
EPS estimate-$0.30

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$4.5M
EPS estimate-$0.21

FAQ

When did Editas Medicine report Q1 2026 earnings?
Editas Medicine (EDIT) reported Q1 2026 earnings on May 5, 2026 before market open.
What were Editas Medicine's Q1 2026 revenue and EPS?
Editas Medicine reported revenue of $2.8M and eps of $-0.26 for Q1 2026.
Did Editas Medicine beat estimates in Q1 2026?
Revenue missed the consensus estimate of $6.4M by $3.5M. EPS beat the consensus estimate of $-0.30 by $0.04.
How did Editas Medicine's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 39.2% from $4.7M a year earlier and eps grew 39.5% from $-0.43.
Where can I find Editas Medicine's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001650664-26-000043) and the 10-Q periodic report (0001650664-26-000045) directly on SEC EDGAR. The filing index links above go to sec.gov.